The FDA warns that both CJC-1295 and ipamorelin carry risks of immunogenicity (triggering immune responses) and cardiovascular effects, including "increased heart rate and systemic vasodilatory reaction." One clinical trial of CJC-1295 was discontinued following a participants death, though the attending physician believed the event was "unrelated to treatment." Neither CJC-1295 nor ipamorelin is FDA-approved
Water, Centella Asiatica Extract (22.7%), Glycerin, Cetyl Ethylhexanoate, Butylene Glycol, Polyglyceryl-3 Methylglucose Distearate, Niacinamide (20,000ppm), Stearic Acid, Sodium Polyacryloyldimethyl Taurate, Silica, Sodium Hyaluronate, Glyceryl Stearate, Beeswax, Butyrospermum Parkii (Shea) Butter, Macadamia Ternifolia Seed Oil, Hydrogenated Polydecene, Betaine, Glutathione (1,000ppm), Trehalose, Adenosine, Citric Acid, Trideceth-10, Disodium EDTA, Sodium Citrate, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Xanthan Gum, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Squalane, Beta-Glucan, Dipropylene Glycol, Hippophae Rhamnoides Fruit Extract, Madecassic Acid, Asiaticoside, Asiatic Acid, Propanediol, Hydroxyacetophenone, 1,2-Hexanediol, Ethylhexylglycerin, Dipotassium Glycyrrhizate This brand is excluded from most Ulta Beauty coupons
December 1, 2011
Substance P via NK1 receptor facilitates hyperactive bladder afferent signaling via action of ROS
